These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10813381)

  • 21. [Impact of hydrogen sulfide donor on pulmonary vascular structure and vasoactive peptides in rats with pulmonary hypertension induced by high pulmonary blood flow].
    Li XH; Du JB; Tang CS
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Apr; 28(2):159-63. PubMed ID: 16733895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute effects of endothelin receptor antagonists on hepatic hemodynamics of cirrhotic and noncirrhotic rats.
    Cavasin MA; Semus H; Pitts K; Peng Y; Sandoval J; Chapo J; Plato CF
    Can J Physiol Pharmacol; 2010 Jun; 88(6):636-43. PubMed ID: 20628429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic endothelin receptor blockade attenuates progressive ventricular dilation and improves cardiac function in rats with myocardial infarction: possible involvement of myocardial endothelin system in ventricular remodeling.
    Fraccarollo D; Hu K; Galuppo P; Gaudron P; Ertl G
    Circulation; 1997 Dec; 96(11):3963-73. PubMed ID: 9403621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endothelin-1 receptor antagonist prevents deterioration of left ventricular function and coronary flow reserve in brain-dead canine heart.
    Oishi Y; Nishimura Y; Tanoue Y; Kajihara N; Imasaka K; Morita S; Yasui H
    J Heart Lung Transplant; 2005 Sep; 24(9):1354-61. PubMed ID: 16143257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduction of progressive burn injury by using a new nonselective endothelin-A and endothelin-B receptor antagonist, TAK-044: an experimental study in rats.
    Battal MN; Hata Y; Matsuka K; Ito O; Matsuda H; Yoshida Y; Kawazoe T
    Plast Reconstr Surg; 1997 May; 99(6):1610-9. PubMed ID: 9145131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of endothelin receptor antagonist (TAK-044) on autotransplanted perfused kidneys in dogs.
    Yoshida K; Kagebayashi Y; Kitauchi T; Kimura S; Yoneda T; Ozono S; Hirao Y; Watanabe T
    Urol Int; 2000; 65(3):148-54. PubMed ID: 11054033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of imidapril on endothelin-1 and ACE gene expression in failing hearts of salt-sensitive hypertensive rats.
    Kobayashi N; Hara K; Higashi T; Matsuoka H
    Am J Hypertens; 2000 Oct; 13(10):1088-96. PubMed ID: 11041163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contribution of the endothelin system to the renal hypoperfusion associated with experimental congestive heart failure.
    Friedrich EB; Muders F; Luchner A; Dietl O; Riegger GA; Elsner D
    J Cardiovasc Pharmacol; 1999 Oct; 34(4):612-7. PubMed ID: 10511139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endothelin antagonism in experimental ischemic heart failure: hemodynamic, structural and neurohumoral effects.
    Mulder P; Richard V; Thuillez C
    Heart Fail Rev; 2001 Dec; 6(4):295-300. PubMed ID: 11447304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibitory effects of TAK-044 on endothelin induced vasoconstriction in various canine arteries and porcine coronary arteries: a comparison with selective ETA and ETB receptor antagonists.
    Awane-Igata Y; Ikeda S; Watanabe T
    Br J Pharmacol; 1997 Feb; 120(3):516-22. PubMed ID: 9031758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deformation-induced endothelin B receptor-mediated smooth muscle cell apoptosis is matrix-dependent.
    Cattaruzza M; Berger MM; Ochs M; Fayyazi A; Füzesi L; Richter J; Hecker M
    Cell Death Differ; 2002 Feb; 9(2):219-26. PubMed ID: 11840172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatoprotective effect of a nonselective endothelin receptor antagonist (TAK-044) in the transplanted liver.
    Yamanaka N; Takaya Y; Oriyama T; Furukawa K; Tanaka T; Tanaka W; Ichikawa N; Yasui C; Ando T; Yamanaka J; Kuroda N; Ko M; Takada M; Imakita M; Kitayama Y; Okamoto E; Sasaki S; Nakagaki I; Hori S; Ito T
    J Surg Res; 1997 Jul; 70(2):156-60. PubMed ID: 9245565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of a new endothelin receptor antagonist, TAK-044, on myocardial stunning in dogs.
    Kitayoshi T; Ikeda S; Kubo K; Awane-Igata Y; Watanabe T; Fujino M
    Eur J Pharmacol; 1996 Jun; 305(1-3):137-43. PubMed ID: 8813544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of endothelin (ET)A and ETB receptors in the hypertrophic effects of ET-1 in rabbit ventricular cardiomyocytes.
    Mullan DM; Bell D; Kelso EJ; McDermott BJ
    J Cardiovasc Pharmacol; 1997 Mar; 29(3):350-9. PubMed ID: 9125673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelin ETA receptor antagonist blocks cardiac hypertrophy provoked by hemodynamic overload.
    Ito H; Hiroe M; Hirata Y; Fujisaki H; Adachi S; Akimoto H; Ohta Y; Marumo F
    Circulation; 1994 May; 89(5):2198-203. PubMed ID: 8181145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the acute effects of a selective endothelin ETA and a mixed ETA/ETB receptor antagonist in heart failure.
    Ohnishi M; Wada A; Tsutamoto T; Fukai D; Kinoshita M
    Cardiovasc Res; 1998 Sep; 39(3):617-24. PubMed ID: 9861304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emergence of smooth muscle cell endothelin B-mediated vasoconstriction in lambs with experimental congenital heart disease and increased pulmonary blood flow.
    Black SM; Mata-Greenwood E; Dettman RW; Ovadia B; Fitzgerald RK; Reinhartz O; Thelitz S; Steinhorn RH; Gerrets R; Hendricks-Munoz K; Ross GA; Bekker JM; Johengen MJ; Fineman JR
    Circulation; 2003 Sep; 108(13):1646-54. PubMed ID: 12963646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of endothelin receptor antagonist TAK-044 on small bowel autograft from a controlled non-heart-beating donor model.
    Sunose Y; Ohwada S; Takeyoshi I; Matsumoto K; Tsutsumi H; Tomizawa N; Kawate S; Morishita Y
    Surgery; 2001 Nov; 130(5):819-25. PubMed ID: 11685191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endothelin system-dependent cardiac remodeling in renovascular hypertension.
    Hocher B; George I; Rebstock J; Bauch A; Schwarz A; Neumayer HH; Bauer C
    Hypertension; 1999 Mar; 33(3):816-22. PubMed ID: 10082493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective ETA receptor blockade prevents left ventricular remodeling and deterioration of cardiac function in experimental heart failure.
    Mulder P; Richard V; Bouchart F; Derumeaux G; Münter K; Thuillez C
    Cardiovasc Res; 1998 Sep; 39(3):600-8. PubMed ID: 9861302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.